Background and Objective

During our clinical practice we have found some limitations by the thoughts and treatments of conventional medicine. Due to personal circumstances we got in contact with complementary therapies widely applied in many countries to the general population in contexts of general medicine, physiotherapy, internal medicine, so we thought to introduce these techniques to our daily practice and study how it affected our patients.

Neural therapy is a technique that uses local anesthetic in very low concentrations in order to restore the membrane potential of the neuron, lost by inflammation, scar, infection, etc. This pathological membrane potential of the neuron causes an absence of transmission of physiological nervous impulse, so that inflammation or pathology to be treated lasts over time. Somehow, the local anesthetic achieves a reset in the nervous system to restart physiological function of the entire organism.

The present study observes the postoperative evolution of the patients after an axillary augmentation mammoplasty, depending on if they were treated with neural therapy as adjuvant treatment or not.

Methods

We performed a non-randomized intervention study in which the presence or absence of pain and the presence or not and degree of periprosthetic encapsulation following Baker´s scale, was measured after transaxillary breast augmentation, and the use of drugs (Nervobión® and Accolate®) depending on if they received or not neural therapy as coadjuvant.

The sample consisted of 178 women with an age range between 17 and 52 years (average of 28.34 years).

The treatment group received 0.33% procaine in the axillary skin scar and the path through which the prosthesis passed during surgery. This treatment was started from the first cure and in the successive visits if the patient required it, with an average of 4 sessions of neural therapy per patient.

We used the statistical package Statistica version 8.0 for the analysis of contingency tables 2 by 2 through X2.

Results

Of the 178 patients included in the study (with 8 losses), we carried out conventional treatment in 101 and coadjuvant neural therapy in 69, verifying a significant improvement in postoperative evolution in patients treated with neural therapy, while the untreated ones required more postsurgical medication..

Conclusions

Although the main limitation of our study is the type of design: intervention study without randomization, in our experience, the use of neural therapy can be recommended as a coadjuvant treatment to reduce capsular contracture and postoperative pain in patients undergoing axillary augmentation mammoplasty.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )